What medication should be given to a pediatric patient with wheezing or bronchospasm?

What medication should be given to a pediatric patient with wheezing or bronchospasm?

• A. Levalbuterol 1.25 mg in 3 mL SVN; repeat until improvement
• B. Ipratropium 2.5 mL 0.02% solution SVN; or DuoNeb 3 mL SVN
• C. Albuterol 2.5 mg in 3 mL SVN; repeat until improvement
• D. Epinephrine 1:1000 0.5 mg SVN

Answer: (C)

A quick-acting bronchodilator given by nebulizer is the treatment most consistent with pediatric wheezing or bronchospasm. Albuterol, a short-acting beta-agonist, rapidly relaxes airway smooth muscle, opens the airways, and improves breathing. The standard pediatric neb dose is 2.5 mg in 3 mL of normal saline, and you can repeat every 20 minutes as needed until there’s clinical improvement. This approach is favored because it provides swift relief with a well-established dosing pattern and safety profile in children. Levalbuterol can be used as an alternative, with a typical dose around 1.25 mg in 3 mL, but many protocols prefer the multi-dose albuterol regimen because it’s more widely tested and readily available. Ipratropium via nebulizer (as DuoNeb) is a helpful adjunct in more severe cases or if partial response to albuterol occurs, but it isn’t the initial single therapy when rapid bronchodilation is the priority. Epinephrine nebulization is not the first-line choice for routine pediatric wheezing and is generally reserved for specific urgent situations under protocol guidance.

A quick-acting bronchodilator given by nebulizer is the treatment most consistent with pediatric wheezing or bronchospasm. Albuterol, a short-acting beta-agonist, rapidly relaxes airway smooth muscle, opens the airways, and improves breathing. The standard pediatric neb dose is 2.5 mg in 3 mL of normal saline, and you can repeat every 20 minutes as needed until there’s clinical improvement. This approach is favored because it provides swift relief with a well-established dosing pattern and safety profile in children.

Levalbuterol can be used as an alternative, with a typical dose around 1.25 mg in 3 mL, but many protocols prefer the multi-dose albuterol regimen because it’s more widely tested and readily available. Ipratropium via nebulizer (as DuoNeb) is a helpful adjunct in more severe cases or if partial response to albuterol occurs, but it isn’t the initial single therapy when rapid bronchodilation is the priority. Epinephrine nebulization is not the first-line choice for routine pediatric wheezing and is generally reserved for specific urgent situations under protocol guidance.